News Image

KILL Dr. Charles Howe of the Mayo Clinic’s Neuroimmunology Department to Join Aditxt Weekly Update on May 2, 2025, to Discuss Newly Announced Preclinical Study Results Sponsored by Aditxt’s Subsidiary Adimune™

Provided By Business Wire

Last update: Apr 18, 2025

Aditxt, Inc. requests that their press release NewsItemId: 20250417385764 “Dr. Charles Howe of the Mayo Clinic’s Neuroimmunology Department to Join Aditxt Weekly Update on May 2, 2025, to Discuss Newly Announced Preclinical Study Results Sponsored by Aditxt’s Subsidiary Adimune™” be killed.

The release was issued in error by Aditxt, Inc..

A replacement release will not be issued at this time.

ADITXT INC

NASDAQ:ADTX (4/21/2025, 8:00:00 PM)

Premarket: 2.23 0 (0%)

2.23

-0.27 (-10.8%)



Find more stocks in the Stock Screener

Follow ChartMill for more